Technology Platform
Global Vision • Leading Pharmaceutical Advancements
UBI Pharma Inc. focuses on cutting-edge drug R&D, leveraging patented technologies for pharmaceutical leadership. Here, we share our expertise and findings with our partners to develop best in class products with global licensing potential.
Innovative Protein Pharmaceutical Technology Platform
UBIP employs the fusion protein technique in the development of two distinct platforms, eliminating concerns about polymer residue within the human body. This approach finds extensive application in the development of various novel biopharmaceuticals.
Specialty Injectable Development Platform
◤ Peptide Formulation Technology Platform
◤ Lyophilized Formulation Technology Platform
Multicomponent Tablet Formulation Technology Platform
UBI Pharma Inc. proudly presents a comprehensive dual-layer tablet development platform, which not only accommodates multicomponent formulations but also exhibits a distinctive capability to mitigate interactions among active ingredients.
Long-Acting Small Molecule Drug Technology Platform
Extended-release formulations improve medication compliance by reducing dosing frequency and maintaining stable blood drug levels, minimizing side effects.